Esperion Inc.

@EsperionInc

Ph 3 focused pharmaceutical company developing LDL-cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and statin intolerance

Ann Arbor, MI
Vrijeme pridruživanja: travanj 2013.

Tweetovi

Blokirali ste korisnika/cu @EsperionInc

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @EsperionInc

  1. prije 21 sat

    2020 should be a monumental year in Esperion’s history. Stay in the know by signing up for our distribution list here

    Poništi
  2. 31. sij

    Esperion received positive CHMP Opinions on both bempedoic acid and bempedoic acid / ezetimibe combination tablets. Read more here

    Poništi
  3. 29. sij

    Are you passionate about Lipid Management for Everybody? Esperion has been focused on this goal for years. Want to be a part of this monumental year in the company’s history? See jobs here.

    Poništi
  4. 28. sij

    The answer is FALSE. If you have HIGH LDL cholesterol levels, your doctor may recommend lifestyle changes and cholesterol-lowering medicine to lower your risk for heart disease and stroke. Learn more here

    Poništi
  5. 27. sij

    The Long Run with recently featured Tim Mayleben, president and chief executive officer of Esperion. Listen here to learn more about Tim's path to leadership and the history of Esperion.

    Poništi
  6. 27. sij

    True or False? If you have low LDL cholesterol levels, your doctor may recommend lifestyle changes and cholesterol-lowering medicine to lower your risk for heart disease and stroke.

    Poništi
  7. 22. sij

    Esperion’s core values drive the world-renowned team of lipid specialists to make a difference every day. Are you driven by collaboration, courage, people, passion and accountability? If so, see job postings here

    Poništi
  8. 20. sij

    Why is Esperion so passionate about Lipid Management for Everybody? Here are a couple of reasons why….

    Poništi
  9. 17. sij

    Esperion is focused on developing targeted, oral, non-statin, LDL-C lowering therapies to address patients’ unmet needs and potentially make a substantial impact. Ready to make an impact for millions of patients? See job postings here.

    Poništi
  10. 14. sij

    Esperion will be presenting at the 38th Annual J.P. Morgan Healthcare Conference tomorrow at 12:00 PM PST/3:00 PM EST. The presentation webcast can be found here

    Poništi
  11. 10. sij

    2019 was a monumental year for Esperion. Our team of lipid management experts continued to develop LDL-C lowering therapies for the potential millions of patients in need. Want to help continue our progress and be a part of the Esperion team? See jobs here

    Poništi
  12. 6. sij

    The Lipid Management Team at ESPERION has deep and broad relationships with other industry-leading experts and businesses, enabling them to extend their impact where and when needed. Learn more about our leadership team here

    Poništi
  13. 2. sij

    The has an impact goal to improve cardiovascular risk of all Americans by 20% and reduce deaths from cardiovascular disease and stroke by 20%, by the year 2020. Learn more here

    Poništi
  14. 30. pro 2019.

    Esperion is focused on LDL-C management for the millions of patients still in in need of additional LDL-C lowering. Do you have a desire to make a large impact? Here are job openings at Esperion.

    Poništi
  15. 27. pro 2019.

    Want to stay up to date on all things Esperion? Visit our website to sign up for ongoing updates as we near the potential PDUFA dates of February 21st and February 26th.

    Poništi
  16. 23. pro 2019.

    Have you or someone you know been affected by ASCVD? Are you looking for an opportunity to make a difference in the ASCVD patient life? Read more about our job openings here

    Poništi
  17. 18. pro 2019.

    The answer is F, all of the choices are symptoms of a heart attack. Early intervention is critical to preventing any cardiovascular event. Read more here.

    Poništi
  18. proslijedio/la je Tweet

    More than 20 million Americans with established and/or familial hypercholesterolemia are on no lowering therapy. How do we change this?

    Poništi
  19. 17. pro 2019.

    In an study, 13.5 million U.S adults did not know of a single symptom of a heart attack. Which of these are symptoms of a heart attack? A. neck pain B. feeling lightheaded C. chest pain D. discomfort in arm/shoulder E. shortness of breath F. all of the choices

    Poništi
  20. 13. pro 2019.

    Our teams are built around our core values of Collaboration, Passion, Courage, Accountability and People. Do these align with your core values? Learn more about our job openings here

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·